MTCI
Cloatre E et al. Legalities of Healing: Handling Alterities at the Edge of Medicine in France, 1980s-2010s. Osiris. 2021;36:328-348. <https://pubmed.ncbi.nlm.nih.gov/34349340/>.
Knox KE et al. Emerging complementary and alternative medicine policy initiatives and the need for dialogue. J Altern Complement Med. 2009 Sep;15(9):959-62. <https://pubmed.ncbi.nlm.nih.gov/19697994/>.
Fischer F. A research roadmap for complementary and alternative medicine – what we need to know by 2020. Forsch Komplementmed. 2014;21(2):e1-16.
Fischer FH et al. High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research. BMC Complement Altern Med. 2014 Feb 6;14:46. <https://pubmed.ncbi.nlm.nih.gov/24499316/>.
Cohen MH. Complementary and integrative medical therapies, the FDA, and the NIH: definitions and regulation. Dermatol Ther. 2003;16(2):77-84. <https://pubmed.ncbi.nlm.nih.gov/12919107/>.
Cloatre E. Law and biomedicine and the making of ‘genuine’ traditional medicines in global health. Crit Public Health. 2019 Jun 4;29(4):424-434. <https://pubmed.ncbi.nlm.nih.gov/31391708/>.
